Technical Analysis for AERI - Aerie Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade F 20.77 2.42% 0.49
AERI closed up 2.42 percent on Wednesday, October 16, 2019, on approximately normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Up
See historical AERI trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Crossed Above 20 DMA Bullish 0.00%
Calm After Storm Range Contraction 0.00%
Multiple of Ten Bullish Other 0.00%
Wide Bands Range Expansion 0.00%
20 DMA Resistance Bearish 2.42%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 2.42%
MACD Bullish Signal Line Cross Bullish 2.42%
Calm After Storm Range Contraction 2.42%
NR7 Range Contraction 2.42%

Older signals for AERI ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Aerie Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapies for the treatment of patients with glaucoma and other diseases of the eye. Its product candidates include dual-action AR-13324, a once-daily eye drop to reduce intraocular pressure (IOP) in patients with glaucoma or ocular hypertension, which has completed a Phase IIb clinical trials; triple-action PG324, a single drop fixed-dose combination of AR-13324 and latanoprost for the treatment of patients with glaucoma; and AR-13533, a dual-action ROCK/NET inhibitor that is in preclinical development stage. The company was founded in 2005 and is headquartered in Bedminster, New Jersey.
Chemistry Pharmaceutical Diseases Chemical Compounds Organic Compounds Glaucoma Alcohols Cyclopropanes Aerie Pharmaceuticals Intraocular Pressure Ocular Hypertension Prostaglandins
Is AERI a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 60.04
52 Week Low 17.51
Average Volume 1,325,930
200-Day Moving Average 34.0547
50-Day Moving Average 21.5669
20-Day Moving Average 20.3423
10-Day Moving Average 19.3715
Average True Range 1.4541
ADX 19.02
+DI 23.7615
-DI 19.3206
Chandelier Exit (Long, 3 ATRs ) 19.8177
Chandelier Exit (Short, 3 ATRs ) 21.8723
Upper Bollinger Band 23.6302
Lower Bollinger Band 17.0544
Percent B (%b) 0.57
BandWidth 32.325745
MACD Line -0.5963
MACD Signal Line -0.7657
MACD Histogram 0.1694
Fundamentals Value
Market Cap 754.68 Million
Num Shares 36.3 Million
EPS -3.26
Price-to-Earnings (P/E) Ratio -6.37
Price-to-Sales 0.00
Price-to-Book 12.18
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 22.33
Resistance 3 (R3) 22.23 21.61 22.07
Resistance 2 (R2) 21.61 21.21 21.66 21.98
Resistance 1 (R1) 21.19 20.97 21.40 21.29 21.90
Pivot Point 20.57 20.57 20.68 20.62 20.57
Support 1 (S1) 20.15 20.17 20.36 20.25 19.64
Support 2 (S2) 19.53 19.93 19.58 19.56
Support 3 (S3) 19.11 19.53 19.47
Support 4 (S4) 19.21